Rolinsatamab
Pivekimab
Camidanlumab
Brentuximab
Inebilizumab
Mirvetuximab
Glembatumumab
Ozuriftamab
Enapotamab
Lorvotuzumab
Naratuximab
Tisotumab
Anetumab
Azintuxizumab
Tamrintamab
Briobacept
Iladatuzumab
Loncastuximab
Lupartumab
Ladiratuzumab